These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22374660)

  • 41. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
    Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A comparison of toxicity and efficacy between busulfan plus fludarabine and busulfan plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia].
    Liu H; Fan ZP; Jiang QL; Huang F; Zhou HS; Zhang X; Yu GP; Wu MQ; Sun J; Liu QF
    Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):880-4. PubMed ID: 23291027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.
    Song WK; Min YH; Kim YR; Lee SC
    Ophthalmology; 2008 Oct; 115(10):1766-70. PubMed ID: 18562004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.
    Farag SS; Wood LL; Schwartz JE; Srivastava S; Nelson RP; Robertson MJ; Abonour R; Secrest A; Cox E; Baute J; Sullivan C; Kane K; Jones DR
    Leukemia; 2011 Apr; 25(4):599-605. PubMed ID: 21252987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor.
    Leung AY; Tse E; Hwang YY; Chan TS; Gill H; Chim CS; Lie AK; Kwong YL
    Am J Hematol; 2013 Jun; 88(6):485-91. PubMed ID: 23512868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HHV-8-related visceral Kaposi's sarcoma following allogeneic HSCT: report of a pediatric case and literature review.
    Sala I; Faraci M; Magnano GM; Sementa A; di Marco E; Garaventa A; Micalizzi C; Lanino E; Morreale G; Moroni C; Castagnola E
    Pediatr Transplant; 2011 Feb; 15(1):E8-11. PubMed ID: 20345616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies.
    Mulanovich VE; Desai PA; Popat UR
    AIDS; 2016 Nov; 30(17):2653-2657. PubMed ID: 27536985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.
    Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):328-337. PubMed ID: 28350553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART.
    Oka Y; Tashiro H; Mizutani-Noguchi M; Koga I; Sugao T; Shirasaki R; Miura T; Akiyama N; Kawasugi K; Fujimori S; Shirafuji N
    Int J Hematol; 2010 Jan; 91(1):140-5. PubMed ID: 20033800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.
    Henrich TJ; Hu Z; Li JZ; Sciaranghella G; Busch MP; Keating SM; Gallien S; Lin NH; Giguel FF; Lavoie L; Ho VT; Armand P; Soiffer RJ; Sagar M; Lacasce AS; Kuritzkes DR
    J Infect Dis; 2013 Jun; 207(11):1694-702. PubMed ID: 23460751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplantation in HIV-infected subjects: is cure possible?
    Zaia JA; Forman SJ
    Hematology Am Soc Hematol Educ Program; 2013; 2013():389-93. PubMed ID: 24319209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell transplantation in HIV-infected patients.
    Krishnan A
    Curr Opin HIV AIDS; 2009 Jan; 4(1):11-5. PubMed ID: 19339935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.
    Hütter G; Zaia JA
    Clin Exp Immunol; 2011 Mar; 163(3):284-95. PubMed ID: 21303358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells.
    Hütter G; Ganepola S
    ScientificWorldJournal; 2011 May; 11():1068-76. PubMed ID: 21552772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation.
    Jensen BO; Knops E; Cords L; Lübke N; Salgado M; Busman-Sahay K; Estes JD; Huyveneers LEP; Perdomo-Celis F; Wittner M; Gálvez C; Mummert C; Passaes C; Eberhard JM; Münk C; Hauber I; Hauber J; Heger E; De Clercq J; Vandekerckhove L; Bergmann S; Dunay GA; Klein F; Häussinger D; Fischer JC; Nachtkamp K; Timm J; Kaiser R; Harrer T; Luedde T; Nijhuis M; Sáez-Cirión A; Schulze Zur Wiesch J; Wensing AMJ; Martinez-Picado J; Kobbe G
    Nat Med; 2023 Mar; 29(3):583-587. PubMed ID: 36807684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.